These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7331934)

  • 1. Distribution and release of GABA in the basal ganglia.
    Korf J; van der Heyden JA; Venema K; Postema F
    Adv Biochem Psychopharmacol; 1981; 30():105-17. PubMed ID: 7331934
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation.
    Bunney BS; Aghajanian GK
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():249-67. PubMed ID: 826996
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo release of newly synthesized GABA in the basal ganglia of the cat.
    Gauchy C; Kemel ML; Glowinski J; Besson MJ
    Adv Biochem Psychopharmacol; 1981; 29():183-91. PubMed ID: 7257927
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of GABA release by dopamine in the substantia nigra.
    Matuszewich L; Yamamoto BK
    Synapse; 1999 Apr; 32(1):29-36. PubMed ID: 10188635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
    Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
    J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.
    Arbilla S; Kamal LA; Langer SZ
    Br J Pharmacol; 1981 Oct; 74(2):389-97. PubMed ID: 7317688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptides in the basal ganglia.
    Graybiel AM
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():135-61. PubMed ID: 2425403
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of GABA in the striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus.
    Scheel-Krüger J; Magelund G; Olianas MC
    Adv Biochem Psychopharmacol; 1981; 30():165-86. PubMed ID: 7036675
    [No Abstract]   [Full Text] [Related]  

  • 12. On the regulation of gamma-aminobutyric acid neurons in caudatus, pallidus and nigra: effects of opioids and dopamine agonists.
    Moroni F; Peralta E; Cheney DL; Costa E
    J Pharmacol Exp Ther; 1979 Feb; 208(2):190-4. PubMed ID: 762651
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of GABA neurons in the expression of striatal motor functions.
    Di Chiara G; Porceddu ML; Imperato A; Morelli M
    Adv Biochem Psychopharmacol; 1981; 30():129-63. PubMed ID: 7036674
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of effects of apomorphine, haloperidol and clozapine on the synthesis and utilization of brain GABA.
    Lindgren S
    J Neural Transm; 1987; 69(1-2):47-57. PubMed ID: 3585320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some aspects of dopamine in the basal ganglia.
    Carlsson A
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():181-9. PubMed ID: 12545
    [No Abstract]   [Full Text] [Related]  

  • 16. Locomotor activity and speed of movements in relation to monoamine-acting drugs.
    Hassler R; Wagner A
    Int J Neurol; 1975; 10(1-4):80-97. PubMed ID: 126971
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dopamine metabolism and the GABA level in the structures of the nigrostriatal and mesolimbic systems of the rat brain in experimental pathology of higher nervous activity].
    Saul'skaia NB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(6):1145-51. PubMed ID: 3245325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of GABA release by dopamine in the rat substantia nigra.
    Reubi JC; Iversen LL; Jessell TM
    Adv Biochem Psychopharmacol; 1978; 19():401-4. PubMed ID: 696468
    [No Abstract]   [Full Text] [Related]  

  • 19. Uptake, localization and release of taurine in the rat basal ganglia.
    Della Corte L; Clarke DJ; Bolam JP; Smith AD
    Adv Exp Med Biol; 1987; 217():285-94. PubMed ID: 3434424
    [No Abstract]   [Full Text] [Related]  

  • 20. Release of endogenous GABA from the rat brain: methodological aspects and the effects of catecholamines.
    van der Heyden JA; Venema K; Lebrun P; Sebens JB; Korf J
    Adv Biochem Psychopharmacol; 1981; 29():193-203. PubMed ID: 6266211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.